GlassScriptPhysician profile
David C Price
NPI 1710984166
$587.52
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $66.16 · 2021: $108 · 2022: $236 · 2023: $44.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $120.05 | 2019-2023 | Stravix |
| Medtronic, INC. | $66.11 | 2022-2023 | Sonicision |
| Allergan, INC. | $65.18 | 2020-2021 | |
| Integra Lifesciences Corporation | $44.37 | 2022 | |
| Innocoll Pharmaceuticals Limited | $43.73 | 2021 | |
| Convatec INC. | $36.62 | 2021-2022 | |
| Acell, INC. | $32.53 | 2019 | |
| Bard Peripheral Vascular, INC. | $26.03 | 2022 | |
| Tela Bio, INC. | $25.78 | 2022 | |
| Shire North American Group INC | $19.36 | 2019 | |
| Ethicon US, LLC | $18.56 | 2022 | |
| Bioventus LLC | $17.88 | 2022 | |
| Covidien LP | $16.87 | 2019 | |
| Heron Therapeutics, INC. | $16.17 | 2021 | |
| Olympus America INC. | $15.10 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12.81 | 2021 | |
| Reprise Biomedical, INC. | $10.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.